If You Invested $10,000 In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now?

Abbott Laboratories ABT discovers, develops, manufactures and sells healthcare products worldwide.

It is set to report its Q1 2025 earnings on April 16. Wall Street analysts expect the company to post EPS of $1.11, up from $0.98 in the year-ago period. According to Benzinga Pro, quarterly revenue is expected to reach $10.67 billion, up from $9.96 billion a year earlier.

If You Bought Abbott Laboratories Stock 10 Years Ago

The company's stock traded at approximately $44.93 per share 10 years ago. If you had invested $10,000, you could have bought roughly 223 shares. Currently, shares trade at $131.31, meaning your investment's value could have grown to $29,225 from stock price appreciation alone. However, Abbott Laboratories also paid dividends during these 10 years. 

Don't Miss:

• Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — you can become an investor for $0.80 per share today.
• Deloitte's fastest-growing software company partners with Amazon, Walmart & Target – Last Chance to get 4,000 of its pre-IPO shares for just $0.26/share!

Abbott Laboratories's dividend yield is currently 1.80%. Over the last 10 years, it has paid about $15.41 in dividends per share, which means you could have made $3,430 from dividends alone. 

Summing up $29,225 and $3,430, we end up with the final value of your investment, which is $32,655. This is how much you could have made if you had invested $10,000 in Abbott Laboratories stock 10 years ago. This means a total return of 226.55%. In comparison, S&P 500 total return for the same period is 229.50%.

What Could The Next 10 Years Bring? 

Abbott Laboratories has a consensus rating of "Buy" and a price target of $129.74 based on the ratings of 28 analysts. The price target implies a potential downside of around 1% from the current stock price.

Trending: If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it?

On Jan. 22, the company announced its Q4 2024 earnings, posting sales of $10.97 billion, up 7.2% year over year. However, as reported by Benzinga, this missed the consensus estimate of $11.01 billion.

Adjusted diluted EPS was $1.34, which met analyst expectations within management's projected range of $1.31-$1.37.

Abbott projects full-year 2025 adjusted EPS of $5.05-$5.25 vs. the consensus of $5.16, with organic sales growth of 7.5%-8.5% and an adjusted operating margin of 23.5%-24.0%. The company expects Q1 2025 adjusted EPS of $1.05-$1.09 vs. the consensus of $1.11.

See Also: This Jeff Bezos-backed startup will allow you to become a landlord in just 10 minutes, with minimum investments as low as $100.

Check out this article by Benzinga, which looks into Abbott Laboratories’ recent short interest.

Given no expected upside potential, growth-focused investors may not find Abbott Laboratories stock attractive. However, the stock can be a good option for income-focused investors, who can benefit from the company's solid dividend yield of 1.80% and consistent hikes. Abbott Laboratories has raised its dividend consecutively for the last 53 years.

Wondering if your investments can get you to a $5,000,000 nest egg? Speak to a financial advisor today. SmartAsset’s free tool matches you up with up to three vetted financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.

You Can Profit From Real Estate Without Being A Landlord

Real estate is a great way to diversify your portfolio and earn high returns, but it can also be a big hassle. Luckily, there are other ways to tap into the power of real estate without owning property. Arrived Home's Private Credit Fund’s has historically paid an annualized dividend yield of 8.1%*, which provides access to a pool of short-term loans backed by residential real estate. The best part? Unlike other private credit funds, this one has a minimum investment of only $100. 

Looking for fractional real estate investment opportunities? The Benzinga Real Estate Screener features the latest offerings.